KYMR logo

Kymera Therapeutics, Inc. (KYMR)

Profile

Full Name

Kymera Therapeutics, Inc.

Ticker

NASDAQ: KYMR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 21, 2020

Indexes

Not included

Website

https://www.kymeratx.com

Employees

208

Key Details

Price

$42.96(-1.81%)

Market cap

$2.80B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$47.07M(-40.11% YoY)

Annual EPS

-$2.98(-18.25% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $42.96
    KYMR price is $42.96

    30-Day Relative Volume

    0.51
    KYMR 30-day relative volume is 0.51

    Price Performance

    Price Most recent change

    -1.81%
    KYMR price was down -1.81% on Aug 1, 2025

    Price YTD change

    +6.79%
    KYMR price is up +6.79% since January 1st

    Price 1-year change

    -3.44%
    KYMR price is down -3.44% year-on-year

    Price 3-year change

    +100%
    KYMR price is up +100% over the past 3 years

    Price Range

    Price All-time high

    $91.92
    KYMR price is currently -53.26% below its historical high of $91.92

    Price 3-year low

    $9.60
    KYMR price is currently +347.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.80B
    KYMR market capitalization is $2.80 billion

    Market cap 3-year change

    +151.2%
    KYMR market capitalization is up +151.2% over the past 3 years

    Market cap All-time high

    $3.90B
    KYMR market capitalization is currently -28.36% below its historical high of $3.90 billion

    Market cap sector rank

    85.22%
    KYMR market capitalization is higher than 85.22% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.76%
    KYMR shares outstanding is up +5.76% year-on-year

    Shares Outstanding 3-Year Change

    +25.6%
    KYMR shares outstanding is up +25.6% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.72
    KYMR beta is 1.72

    200-day SMA

    $39.25
    KYMR price is currently +9.47% above its 200-day simple moving average

    50-day SMA

    $43.23
    KYMR price is currently -0.63% below its 50-day simple moving average

    RSI

    42.21
    KYMR 14-day relative strength index is 42.21

    Volume

    0.51
    KYMR 30-day relative volume is 0.51

    ATR

    $1.57
    KYMR average true range is $1.57

    10-day Historical Volatility

    25.64%
    KYMR 10-day historical volatility is 25.64%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $47.07M
    KYMR annual revenue is $47.07 million

    Revenue Analysts estimate

    $79.96M
    KYMR annual revenue is currently -41.13% lower than the consensus analysts' forecast

    Revenue 1-year change

    -40.11%
    KYMR annual revenue is down -40.11% year-on-year

    Revenue Sector rank

    45.31%
    KYMR annual revenue is higher than 45.31% of companies in Healthcare sector

    EPS

    EPS

    -$2.98
    KYMR annual earnings per share is -$2.98

    EPS Analysts estimate

    -$3.49
    KYMR annual earnings per share is currently -14.49% lower than the consensus analysts' forecast

    EPS 1-year change

    -18.25%
    KYMR annual earnings per share is down -18.25% year-on-year

    EPS Sector rank

    30.62%
    KYMR annual earnings per share is higher than 30.62% of companies in Healthcare sector

    Profit

    Gross profit

    -
    KYMR annual gross profit value is unknown

    Gross margin

    -
    KYMR annual gross profit margin value is unknown

    Operating profit

    -$256.71M
    KYMR annual operating income is -$256.71 million

    Operating margin

    -545.36%
    KYMR annual operating profit margin is -545.36%

    Net income

    -$223.86M
    KYMR annual net profit is -$223.86 million

    Net margin

    -475.57%
    KYMR annual net profit margin is -475.57%

    Expenses

    Total expenses

    $303.78M
    KYMR annual total expenses is $303.78 million

    Operating expenses

    $303.78M
    KYMR annual total operating expenses is $303.78 million

    Cost of goods sold

    -
    KYMR annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $63.53M
    KYMR annual SGA is $63.53 million

    Depreciation and amortization

    $7.37M
    KYMR annual depreciation & amortization is $7.37 million

    Interest expense

    $249.00K
    KYMR annual interest expense is $249.00 thousand

    Income tax

    -
    KYMR annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$223.61M
    KYMR annual earnings before interest & taxes is -$223.61 million

    EBITDA

    -$216.24M
    KYMR annual EBITDA is -$216.24 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $978.03M
    KYMR annual total assets is $978.03 million

    Non current assets

    $467.77M
    KYMR annual long term assets is $467.77 million

    Current assets

    $510.27M
    KYMR annual total current assets is $510.27 million

    Cash and cash equivalents

    $120.26M
    KYMR annual cash & cash equivalents is $120.26 million

    Accounts receivable

    $0.00
    KYMR annual accounts receivable is $0.00

    Inventory

    -
    KYMR annual inventory value is unknown

    Liabilities

    Total liabilities

    $142.42M
    KYMR annual total liabilities is $142.42 million

    Long term liabilities

    $74.65M
    KYMR annual total long term liabilities is $74.65 million

    Current liabilities

    $67.77M
    KYMR annual total current liabilities is $67.77 million

    Accounts payable

    $5.99M
    KYMR annual accounts payable is $5.99 million

    Debt

    Total debt

    $87.76M
    KYMR annual total debt is $87.76 million

    Total debt 1-year change

    +3.65%
    KYMR annual total debt is up +3.65% year-on-year

    Long term debt

    $74.65M
    KYMR annual long term debt is $74.65 million

    Short term debt

    $13.11M
    KYMR annual short term debt is $13.11 million

    Equity & Capital

    Shareholders equity

    $835.62M
    KYMR annual stockholders equity is $835.62 million

    Book value

    $835.62M
    KYMR annual book value is $835.62 million

    Retained earnings

    -$754.61M
    KYMR annual retained earnings is -$754.61 million

    Working capital

    $442.50M
    KYMR annual working capital is $442.50 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$194.50M
    KYMR annual cash flow from operations is -$194.50 million

    Cash from operations 1-year change

    -89.16%
    KYMR annual cash flow from operations is down -89.16% year-on-year

    Cash from investing

    -$404.08M
    KYMR annual cash flow from investing activities is -$404.08 million

    Cash from investing 1-year change

    -388.86%
    KYMR annual cash flow from investing activities is down -388.86% year-on-year

    Cash from financing

    $608.85M
    KYMR annual cash flow from financing activities is $608.85 million

    Cash from financing 1-year change

    +14424.12%
    KYMR annual cash flow from financing activities is up +14424.12% year-on-year

    CAPEX

    CAPEX

    $12.84M
    KYMR annual capital expenditures is $12.84 million

    CAPEX 1-year change

    -62.77%
    KYMR annual capital expenditures is down -62.77% year-on-year

    Free Cash Flow

    Free cash flow

    -$207.34M
    KYMR annual free cash flow is -$207.34 million

    Free cash flow 1-year change

    -51.01%
    KYMR annual free cash flow is down -51.01% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    KYMR annual gross profit margin value is unknown

    Operating margin

    -545.36%
    KYMR annual operating profit margin is -545.36%

    Net margin

    -475.57%
    KYMR annual net profit margin is -475.57%

    ROA & ROE

    ROA

    -28.81%
    KYMR annual return on assets is -28.81%

    ROE

    -36.38%
    KYMR annual return on equity is -36.38%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    KYMR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    KYMR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.56
    KYMR price to book ratio is 3.56

    PB ratio Sector rank

    72.95%
    KYMR price to book ratio is higher than 72.95% of companies in Healthcare sector

    PS Ratio

    PS ratio

    47.51
    KYMR price to sales ratio is 47.51

    PS ratio Sector rank

    90%
    KYMR price to sales ratio is higher than 90% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.79B
    KYMR enterprise value is $2.79 billion

    Enterprise value Sector rank

    84.35%
    KYMR enterprise value is higher than 84.35% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -12.01
    KYMR EV/EBITDA is -12.01

    EV/EBITDA Sector rank

    11.85%
    KYMR EV/EBITDA is higher than 11.85% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.53
    KYMR annual current ratio is 7.53

    Quick ratio

    -
    KYMR annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    KYMR annual debt to equity ratio is 0.00

    Interest coverage ratio

    -898.03
    KYMR annual interest coverage ratio is -898.03

    Risk & Stability

    Piotroski F-Score

    -
    KYMR piotroski f-score value is unknown

    Altman Z-Score

    10.54
    KYMR altman z-score is 10.54

    Analyst ratings

    Recent major analysts updates

    Jun 27, 25 Oppenheimer
    Outperform
    Jun 26, 25 Wells Fargo
    Overweight
    Jun 26, 25 HC Wainwright & Co.
    Buy
    Jun 3, 25 Morgan Stanley
    Overweight
    Jun 3, 25 JP Morgan
    Overweight
    Jun 3, 25 B. Riley Securities
    Buy
    May 13, 25 UBS
    Buy
    May 12, 25 JP Morgan
    Overweight
    May 12, 25 Guggenheim
    Buy
    May 12, 25 B. Riley Securities
    Neutral

    Institutional Ownership

    Screeners with KYMR included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Kymera Therapeutics, Inc.?
    • Does Kymera Therapeutics, Inc. pay dividends?
    • What sector is Kymera Therapeutics, Inc. in?
    • What industry is Kymera Therapeutics, Inc. in?
    • What country is Kymera Therapeutics, Inc. based in?
    • When did Kymera Therapeutics, Inc. go public?
    • Is Kymera Therapeutics, Inc. in the S&P 500?
    • Is Kymera Therapeutics, Inc. in the NASDAQ 100?
    • Is Kymera Therapeutics, Inc. in the Dow Jones?
    • When was Kymera Therapeutics, Inc.'s last earnings report?
    • When does Kymera Therapeutics, Inc. report earnings?

    What is the ticker symbol for Kymera Therapeutics, Inc.?

    The ticker symbol for Kymera Therapeutics, Inc. is NASDAQ:KYMR

    Does Kymera Therapeutics, Inc. pay dividends?

    No, Kymera Therapeutics, Inc. does not pay dividends

    What sector is Kymera Therapeutics, Inc. in?

    Kymera Therapeutics, Inc. is in the Healthcare sector

    What industry is Kymera Therapeutics, Inc. in?

    Kymera Therapeutics, Inc. is in the Biotechnology industry

    What country is Kymera Therapeutics, Inc. based in?

    Kymera Therapeutics, Inc. is headquartered in United States

    When did Kymera Therapeutics, Inc. go public?

    Kymera Therapeutics, Inc.'s initial public offering (IPO) was on August 21, 2020

    Is Kymera Therapeutics, Inc. in the S&P 500?

    No, Kymera Therapeutics, Inc. is not included in the S&P 500 index

    Is Kymera Therapeutics, Inc. in the NASDAQ 100?

    No, Kymera Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Kymera Therapeutics, Inc. in the Dow Jones?

    No, Kymera Therapeutics, Inc. is not included in the Dow Jones index

    When was Kymera Therapeutics, Inc.'s last earnings report?

    Kymera Therapeutics, Inc.'s most recent earnings report was on May 9, 2025

    When does Kymera Therapeutics, Inc. report earnings?

    The next expected earnings date for Kymera Therapeutics, Inc. is August 7, 2025
    On this page